Common use of Term and Expiration Clause in Contracts

Term and Expiration. This Agreement shall be effective as of the Effective Date and unless terminated earlier pursuant to Section 9.2 or 9.3, this Agreement shall continue in effect until expiration of all royalty obligations hereunder. Upon expiration of all royalty obligations under this Agreement, such licenses to Merck pursuant to Sections 3.1(a), 3.1(b) and 3.2 as were in effect immediately prior to such expiration shall become fully paid-up, perpetual licenses. *** Confidential Treatment Requested

Term and Expiration. This Agreement shall be effective as of the Effective Date and unless terminated earlier pursuant to Section 9.2 Sections 8.2 or 9.38.3, this Agreement shall continue in effect until expiration of all royalty obligations hereunderunder Article 5. Upon expiration of all royalty obligations under this Agreement, such Merck's licenses to Merck pursuant to Sections 3.1(a), 3.1(b) Section 3.1 and 3.2 as were in effect immediately prior to such expiration shall become fully paid-up, perpetual licenses. *** Confidential Treatment Requested.

Term and Expiration. This Agreement shall be effective as of the Effective Date and unless terminated earlier pursuant to Section 9.2 Sections 8.2 or 9.38.3 below, this Agreement shall continue in effect until expiration of all royalty obligations hereunder. Upon expiration of all royalty obligations under this Agreement, such MERCK’s licenses to Merck pursuant to Sections 3.1(a), 3.1(b) and 3.2 as were in effect immediately prior to such expiration Section 3.1 shall become fully paid-up, perpetual licenses. *** Confidential Treatment Requested.

Term and Expiration. This Agreement shall be effective as of the Effective Date and unless terminated earlier pursuant to Section 9.2 Sections 11.2 or 9.311.3, this Agreement shall continue in full force and effect until expiration of all royalty payment obligations hereunderunder Article 7 have been made by Merck or otherwise expired for all Licensed Products in the Territory (the “Term”). Upon expiration (but not early termination) of this Agreement and provided that all royalty obligations under this Agreementpayments hereunder have been made, such Merck’s licenses to Merck pursuant to Sections 3.1(a), 3.1(b) and 3.2 as were in effect immediately prior to such expiration Section 3.1 shall become fully paid-up, perpetual licenses. *** Confidential Treatment Requested.

Term and Expiration. This Agreement shall be effective as of the ------------------- Effective Date and unless terminated earlier pursuant to Section 9.2 Sections 7.2 or 9.37.3 below, the term of this Agreement shall continue in effect until expiration of all royalty obligations hereunder. Upon expiration of all royalty obligations under this Agreementhereunder, such Merck's licenses to Merck pursuant to Sections 3.1(a), 3.1(b) and 3.2 as were in effect immediately prior to such expiration Article 2 shall become fully paid-up, perpetual licenses. *** Confidential Treatment Requested.

Term and Expiration. This Agreement shall be effective as of the Effective Date and and, unless terminated earlier pursuant to Section 9.2 under Sections 8.2 or 9.38.3 below, this Agreement shall continue in effect until expiration of all royalty obligations hereunder. Upon expiration of this Agreement due to expiration of all royalty obligations under this Agreementhereunder, such MERCK’s licenses to Merck pursuant to Sections 3.1(a), 3.1(b) and 3.2 as were in effect immediately prior to such expiration Section 3.1 shall become fully paid-up, perpetual licenses. *** Confidential Treatment Requested.

Term and Expiration. This Agreement shall be effective as of the Effective Date and unless terminated earlier pursuant to Section Sections 9.2 or 9.39.3 below, the term of this Agreement shall continue in effect until expiration of all royalty obligations hereunder. Upon expiration of this Agreement due to expiration of all royalty obligations under this Agreementhereunder, such MERCK's licenses to Merck pursuant to Sections 3.1(a), 3.1(b) Section 3.1 and 3.2 as were in effect immediately prior to such expiration shall become fully paid-up, perpetual licenses. *** Confidential Treatment Requested.

Term and Expiration. This Agreement shall be effective as of the Effective Date and unless terminated earlier pursuant to Section 9.2 Sections 8.2 or 9.38.3 below, this Agreement shall continue in effect until expiration of all royalty payment obligations hereunder. Upon expiration of all royalty obligations under this Agreement, such MERCK’s licenses to Merck pursuant to Section 3.1 (other than Sections 3.1(a), 3.1(b3.1(e) and 3.2 as were in effect immediately prior to such expiration 3.1(f)) shall become fully paid-up, perpetual licenses. *** Confidential Treatment Requested.

Term and Expiration. This Agreement shall be effective as of the Effective Date and unless terminated earlier pursuant to Section 9.2 Sections 8.2 or 9.38.3 below, the term of this Agreement shall continue in effect until expiration of all royalty obligations hereunder. Upon expiration of this Agreement due to expiration of all royalty obligations under this Agreementhereunder, such Merck's licenses to Merck pursuant to Sections 3.1(a), 3.1(b) and 3.2 as were in effect immediately prior to such expiration Section 3.1 shall become fully paid-up, perpetual licenses. *** Confidential Treatment Requested.

Term and Expiration. This Agreement shall be effective as of the Effective Date and unless terminated earlier pursuant to Section 9.2 Sections 8.2 or 9.38.3 below, this Agreement shall continue in effect until expiration of all royalty payment obligations hereunder. Upon expiration of this Agreement due to the expiration of all royalty obligations under this Agreementpayment obligations, such MERCK’s licenses to Merck pursuant to Sections 3.1(a), 3.1(b) Section 3.1 and 3.2 as were in effect immediately prior to such expiration shall become fully paid-up, perpetual licenses. *** Confidential Treatment Requested.

Term and Expiration. This Agreement shall be effective as of the Effective Date and unless terminated earlier pursuant to Section 9.2 Sections 8.2 or 9.38.3 below, the term of this Agreement shall continue in effect until expiration of all royalty obligations hereunder. Upon expiration of this Agreement due to expiration of all royalty obligations under this Agreementhereunder, such MERCK's licenses to Merck pursuant to Sections 3.1(a), 3.1(b) and 3.2 as were in effect immediately prior to such expiration Section 3.1 shall become non-exclusive, fully paid-up, perpetual licenses. *** Confidential Treatment Requestedlicenses which shall be limited to the Field.

Term and Expiration. This Agreement shall be effective as of ------------------- the Effective Date and unless terminated earlier pursuant to Section 9.2 Sections 7.2 or 9.37.3 below, the term of this Agreement shall continue in effect until expiration of all royalty obligations hereunder. Upon expiration of all royalty obligations under this Agreementhereunder, such Merck's licenses to Merck pursuant to Sections 3.1(a), 3.1(b) and 3.2 as were in effect immediately prior to such expiration Article 2 shall become fully paid-up, perpetual licenses. *** Confidential Treatment Requested.

Term and Expiration. This Agreement shall be become effective as of upon the Effective Date and unless and, if not otherwise terminated earlier pursuant to Section 9.2 or 9.3this Article 8, this Agreement shall continue in effect until expire upon the expiration of all royalty obligations hereunderhereunder for any Products related thereto. Upon expiration of all royalty obligations this Agreement under this AgreementSection 8.1, such Merck’s licenses to Merck pursuant to Sections 3.1(a), 3.1(b) Section 3.1 and Section 3.2 as were in effect immediately prior to such expiration shall become fully paid-up, irrevocable, perpetual licenses. *** Confidential Treatment Requested.

Term and Expiration. This Agreement shall be effective as of the Effective Date and unless terminated earlier pursuant to Section 9.2 Sections 8.2 or 9.38.3 below, this Agreement shall continue in effect until expiration of all royalty obligations hereunder. Upon expiration of all royalty obligations under this Agreement, such Merck’s licenses to Merck pursuant to Sections 3.1(a), 3.1(b) Section 3.1 and 3.2 as were in effect immediately prior to such expiration shall become fully paid-up, perpetual licenses. *** Confidential Treatment Requested.

Term and Expiration. 9.1.1 This Agreement shall be effective as of the Effective Date and unless terminated earlier pursuant to Section Sections 9.2 or 9.39.3 below, this Agreement shall continue in effect until expiration of all royalty obligations hereunder. Upon natural expiration of all royalty obligations under this Agreement, such Merck’s licenses to Merck pursuant to Sections 3.1(a), 3.1(b) and 3.2 as were in effect immediately prior to such expiration Section 3.1 shall become fully paid-up, perpetual licenses. *** Confidential Treatment Requested.

Term and Expiration. This Agreement shall be effective as of the Effective Date and unless terminated earlier pursuant to Section 9.2 Sections 8.2 or 9.38.3, this Agreement shall continue in effect until expiration of all royalty obligations hereunderunder Article 5. Upon expiration of all royalty obligations under this Agreement, such Merck’s licenses to Merck pursuant to Sections 3.1(a), 3.1(b) Section 3.1 and 3.2 as were in effect immediately prior to such expiration shall become fully paid-up, perpetual licenses. *** Confidential Treatment Requested.

Term and Expiration. This Agreement shall be effective as of the Effective Closing Date and and, unless terminated earlier pursuant to Section Sections 9.2 or 9.39.3 below, this Agreement shall continue in effect until expiration of all royalty obligations hereunder. Upon expiration of all royalty obligations under this Agreement, such MERCK's and DOV's licenses to Merck pursuant to Sections 3.1(a), 3.1(b) Section 3.1 and Section 3.2 as were in effect immediately prior to such expiration shall become fully paid-up, perpetual licenses. *** Confidential Treatment Requested.

Term and Expiration. This Agreement shall be effective as of the Effective Date and unless terminated earlier pursuant to Section 9.2 Sections 8.2 or 9.38.3 below, this Agreement shall continue in effect until expiration of all royalty obligations hereunder. Upon expiration of all royalty obligations under this Agreement, such the licenses granted to Merck pursuant to Sections 3.1(a), 3.1(b) Section 3.1 and 3.2 as were in effect immediately prior to such expiration shall become fully paid-up, perpetual licenses. *** Confidential Treatment Requested.

Term and Expiration. This Agreement shall be effective as of the Effective Date Date, and unless terminated earlier pursuant to Section 9.2 8.2 or 9.3Section 8.3, this Agreement shall continue in full force and effect until one or more Products has received Marketing Authorization and, thereafter, until expiration of all royalty obligations hereunderhereunder (the “Term”). Upon expiration of all royalty obligations under this Agreement, such Merck’s licenses to Merck pursuant to Sections 3.1(a), 3.1(b) and 3.2 as were in effect immediately prior to such expiration Section 3.1 shall become fully paid-up, perpetual licenses. *** Confidential Treatment Requested#00000x000 Confidential

Term and Expiration. This Agreement shall be effective as of the Effective Date and unless terminated earlier pursuant to Section 9.2 Sections 8.2 or 9.38.3, this Agreement shall continue in effect until expiration of all royalty obligations hereunderunder Article 5. Portions of this exhibit, indicated by the xxxx “[***],” have been redacted pursuant to a confidential treatment request. An unredacted version of this exhibit has been filed separately with the Commission. Upon expiration of all royalty obligations under this Agreement, such Merck’s licenses to Merck pursuant to Sections 3.1(a), 3.1(b) Section 3.1 and 3.2 as were in effect immediately prior to such expiration shall become fully paid-up, perpetual licenses. *** Confidential Treatment Requested.

Term and Expiration. This Agreement shall be effective as of the Effective Date and unless terminated earlier pursuant to Section 9.2 Sections 8.2 or 9.38.3 below, this Agreement shall continue in effect until expiration of all royalty obligations hereunder. Upon expiration of all royalty obligations under this Agreement, such Merck's licenses to Merck pursuant to Sections 3.1(a), 3.1(b) 3.1.1 and 3.2 as were in effect immediately prior to such expiration 3.1.2 shall become fully paid-up, perpetual licenses. *** Confidential Treatment Requested.

Term and Expiration. This Agreement shall be effective as of the Effective Date and unless terminated earlier pursuant to Section 9.2 Sections 8.2 or 9.38.3, this Agreement shall continue in full force and effect until one or more Products has received Marketing Authorization and, thereafter, until expiration of all royalty obligations hereunder. Upon expiration of all royalty obligations under this Agreement, such Merck’s licenses to Merck pursuant to Sections 3.1(a), 3.1(b) Section 3.1 and 3.2 as were in effect immediately prior to such expiration shall become fully paid-up, perpetual licenses. licenses [*** Confidential Treatment Requested*].

Term and Expiration. This Agreement shall be effective as of the Effective Date and unless terminated earlier pursuant to Section 9.2 Sections 8.2 or 9.38.3, this Agreement shall continue in full force and effect until one or more Products has received Marketing Authorization and, thereafter, until expiration of all royalty obligations hereunder. Upon expiration of all royalty obligations under this Agreement, such Merck's licenses to Merck pursuant to Sections 3.1(a), 3.1(b) Section 3.2.1 and 3.2 as were in effect immediately prior to such expiration 3.2.2 shall become fully paid-up, perpetual licenses. *** Confidential Treatment Requested.

Term and Expiration. This Agreement shall be effective as of the Effective Date and unless terminated earlier pursuant to Section 9.2 Sections 8.2 or 9.38.3, this Agreement shall continue in full force and effect until one or more Licensed Products has received Marketing Authorization and, thereafter, until expiration of all royalty obligations hereunder. Upon expiration of all royalty obligations under this Agreement, such Merck’s licenses to Merck pursuant to Sections 3.1(a), 3.1(b) Section 3.2 and 3.2 as were in effect immediately prior to such expiration 3.3 shall become fully paid-up, perpetual licenses. *** Confidential Treatment Requested.

Term and Expiration. This Agreement shall be effective as of the Effective Date and unless terminated earlier pursuant to Section 9.2 Sections 8.2 or 9.38.3 below, the term of-this Agreement shall continue in effect until expiration of all royalty obligations hereunder. Upon expiration of this Agreement due to expiration of all royalty obligations under this Agreementhereunder, such Merck's licenses to Merck pursuant to Sections 3.1(a), 3.1(b) and 3.2 as were in effect immediately prior to such expiration Section 3.1 shall become fully paid-up, perpetual licenses. *** Confidential Treatment Requested.

Term and Expiration. This Agreement shall be effective as of the Effective Date and and, unless terminated earlier pursuant to Section 9.2 under Sections 8.2 or 9.38.3, this Agreement shall continue in effect until expiration of all royalty obligations hereunderunder this Agreement. Upon expiration of this Agreement due to expiration of all royalty obligations under this Agreement, such licenses to Merck pursuant to Sections 3.1(a)Subsection 5.4.1, 3.1(b) and 3.2 as were in effect immediately prior MERCK’s licenses pursuant to such expiration Article III shall become fully paid-up, perpetual licenses. *** Confidential Treatment Requested.

Term and Expiration. This Agreement shall be effective as of the Effective Date and unless terminated earlier pursuant to Section 9.2 Sections 13.3 or 9.313.4, this Agreement shall continue in full force and effect until expiration of all royalty payment (including sharing of US Adjusted Net Sales) obligations hereunderhereunder (the “Term”). Upon expiration of all royalty obligations under this Agreement, such Merck's licenses to Merck pursuant to Sections 3.1(a), 3.1(b) Section 2.1.1 and 3.2 as were in effect immediately prior to such expiration 2.2.1 shall become fully paid-up, perpetual licenses. *** Confidential Treatment Requestedlicenses and Endocyte’s covenant in Section 2.2.2 shall continue until such time as Merck is no longer selling Product.

Term and Expiration. This Agreement shall be effective as of the Effective Date and unless terminated earlier pursuant to Section Sections 9.2 or 9.3, this Agreement shall continue in effect until expiration of all royalty obligations hereunder. Upon expiration of all royalty obligations under this Agreement, such Merck’s licenses to Merck pursuant to Sections 3.1(a)Section 3.1, 3.1(b) and 3.2 as were in effect immediately prior to such expiration if granted, shall become fully paid-up, perpetual licenses. *** Confidential Treatment RequestedFor the purposes of this Agreement, “

Term and Expiration. This Agreement shall be effective as of the Effective Date and unless terminated earlier pursuant to Section 9.2 Sections 8.2 or 9.38.3, this Agreement shall continue in effect until expiration of all royalty obligations hereunder. Upon expiration of all royalty obligations under this Agreement, such (a) Merck’s licenses to Merck pursuant to Sections 3.1(a), 3.1(b) and 3.2 as were in effect immediately prior to such expiration under Article 3 shall become fully paid-up, perpetual licenses. *** Confidential Treatment Requested; and (b) FHT’s license granted pursuant to Section 3.2.2, if in effect at such time, will become a perpetual, fully-paid up license.

Term and Expiration. This Agreement shall be effective as of the Effective Date and unless terminated earlier pursuant to Section 9.2 Sections 8.2 or 9.38.3 below, the term of this Agreement shall continue in effect until expiration of all royalty obligations hereunder. Upon expiration of this Agreement due to expiration of all royalty obligations under this Agreementhereunder, such MERCK's licenses to Merck pursuant to Sections 3.1(a), 3.1(b) Section 3.1 and 3.2 as were in effect immediately prior to such expiration shall become fully paid-up, perpetual licenses. *** Confidential Treatment Requested.